Expression of COX-2 in uterine adenomyosis and its clinical significance
Wenshu Chen
Abstract
Wenshu Chen
Abstract
Objective To investigate the expression of Cyclooxygenase-2 (COX-2) in uterine adenomyosis and its clinical significance. Methods The expression of COX-2 was examined by immunohistochemistry SP method, in ectopic endometrium and eutopic endometrium of patients with uterine adenomyosis, the results were compared with normal endometrium. Results COX-2 expression in ectopic or eutopic endometrium with adenomyosis was significantly higher than that in normal endometrium. (P 0.05) . No statistically significant difference was found between ectopic endometrium and eutopic endometrium of adenomyosis(P0.05). And there were no significant differences in COX-2 expression between proliferative phase and secretive phase of endometrium. Conclusion High expression of COX-2 may be involved in the pathogenesis and development of uterine adenomyosis, which may provide potent target for treatment of adenomyosis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the expression of Cyclooxygenase-2 (COX-2) in uterine adenomyosis and its clinical significance. Methods The expression of COX-2 was examined by immunohistochemistry SP method, in ectopic endometrium and eutopic endometrium of patients with uterine adenomyosis, the results were compared with normal endometrium. Results COX-2 expression in ectopic or eutopic endometrium with adenomyosis was significantly higher than that in normal endometrium. (P 0.05) . No statistically significant difference was found between ectopic endometrium and eutopic endometrium of adenomyosis(P0.05). And there were no significant differences in COX-2 expression between proliferative phase and secretive phase of endometrium. Conclusion High expression of COX-2 may be involved in the pathogenesis and development of uterine adenomyosis, which may provide potent target for treatment of adenomyosis.
Key concepts: Adenomyosis, Medicine, Endometrium, Immunohistochemistry, Pathogenesis, Gynecology, Clinical significance, Myometrium